Danes get advice on EU innovation funding:
This article was originally published in Clinica
Executive Summary
Danish industry is receiving a helping hand from its trade association to benefit from R&D funding available under the EU's 6th framework programme (FP6). Medicoindustrien is holding a meeting on September 24 on how companies can obtain funding. An EU consultant will provide an overview of the framework programme, with special focus on the two areas relevant for the medical device industry - the LifeScience Programme (biotech) and the Nano Programme (materials). There will also be reports from those experienced in obtaining funding for medical devices under EU framework programmes.
You may also be interested in...
Japan Regulatory Update: Revised Law Widens RWD Scope, Price Revisions/Listings
Japan now allows pseudonymized personal data for medical use under a licensing system for wider use of real-world data. Meanwhile, a national cost-effectiveness assessment scheme has slashed reimbursement prices for Lagevrio and Kerendia, and Alexion’s Voydeya has been added to the reimbursement tariff.
Abbott's ‘Bedrock Of Good Health’ Nutritionals Business Faces Mounting Infant Formula Litigation
Nutritional product business had 5.1% Q1 sales growth and is like Abbott’s other segments, “super well-aligned to the global demographics and trends in health care,” says CEO Ford. But as it defends complaints of damages from powder formulas made at facility found with unsafe levels of bacterial contaminants, Abbott’s also targeted in litigation alleging failure to warn about risk of infants born prematurely developing necrotizing enterocolitis if fed cow’s milk-based formula.
‘Core Pillars’ Of Safety And Innovation Take Center Stage In FDA Reports
The US FDA has issued a pair of reports focused on device safety and innovation. The reports describe recent steps the agency has taken to improve in the two areas, and what it plans to do next.